| Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium IG McKeith, DW Dickson, J Lowe, M Emre, JT O'brien, H Feldman, ... Neurology 65 (12), 1863-1872, 2005 | 5859* | 2005 |
| Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines I Litvan, JG Goldman, AI Tröster, BA Schmand, D Weintraub, RC Petersen, ... Movement disorders 27 (3), 349-356, 2012 | 1643 | 2012 |
| Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients D Weintraub, J Koester, MN Potenza, AD Siderowf, M Stacy, V Voon, ... Archives of neurology 67 (5), 589-595, 2010 | 1315 | 2010 |
| Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease LS Schneider, PN Tariot, KS Dagerman, SM Davis, JK Hsiao, MS Ismail, ... New England Journal of Medicine 355 (15), 1525-1538, 2006 | 1229 | 2006 |
| Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease S Hoops, S Nazem, AD Siderowf, JE Duda, SX Xie, MB Stern, ... Neurology 73 (21), 1738-1745, 2009 | 897 | 2009 |
| The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease K Seppi, D Weintraub, M Coelho, S Perez‐Lloret, SH Fox, ... Movement disorders 26 (S3), S42-S80, 2011 | 874 | 2011 |
| Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis D Aarsland, K Bronnick, C Williams-Gray, D Weintraub, K Marder, ... Neurology 75 (12), 1062-1069, 2010 | 768 | 2010 |
| Association of dopamine agonist use with impulse control disorders in Parkinson disease D Weintraub, AD Siderowf, MN Potenza, J Goveas, KH Morales, JE Duda, ... Archives of neurology 63 (7), 969-973, 2006 | 724 | 2006 |
| MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD‐MCI I Litvan, D Aarsland, CH Adler, JG Goldman, J Kulisevsky, B Mollenhauer, ... Movement disorders 26 (10), 1814-1824, 2011 | 685 | 2011 |
| Depression rating scales in Parkinson's disease: critique and recommendations A Schrag, P Barone, RG Brown, AFG Leentjens, WM McDonald, ... Movement disorders 22 (8), 1077-1092, 2007 | 632 | 2007 |
| Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial P Barone, W Poewe, S Albrecht, C Debieuvre, D Massey, O Rascol, ... The Lancet Neurology 9 (6), 573-580, 2010 | 516 | 2010 |
| Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease D Weintraub, PJ Moberg, JE Duda, IR Katz, MB Stern Journal of the American Geriatrics Society 52 (5), 784-788, 2004 | 452 | 2004 |
| Validation of the questionnaire for impulsive‐compulsive disorders in Parkinson's disease D Weintraub, S Hoops, JA Shea, KE Lyons, R Pahwa, ... Movement disorders: official journal of the Movement Disorder Society 24 (10 …, 2009 | 385 | 2009 |
| Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial AP Porsteinsson, LT Drye, BG Pollock, DP Devanand, C Frangakis, ... Jama 311 (7), 682-691, 2014 | 384 | 2014 |
| Cognitive decline in Parkinson disease D Aarsland, B Creese, M Politis, KR Chaudhuri, D Weintraub, C Ballard Nature Reviews Neurology 13 (4), 217-231, 2017 | 376 | 2017 |
| Impulse control disorders in Parkinson disease: a multicenter case–control study V Voon, M Sohr, AE Lang, MN Potenza, AD Siderowf, J Whetteckey, ... Annals of neurology 69 (6), 986-996, 2011 | 371 | 2011 |
| Montreal cognitive assessment performance in patients with Parkinson's disease with “normal” global cognition according to mini‐mental state examination score S Nazem, AD Siderowf, JE Duda, T Ten Have, A Colcher, SS Horn, ... Journal of the American Geriatrics Society 57 (2), 304-308, 2009 | 370 | 2009 |
| A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease RS Turner, RG Thomas, S Craft, CH Van Dyck, J Mintzer, BA Reynolds, ... Neurology 85 (16), 1383-1391, 2015 | 367 | 2015 |
| Parkinson's disease--Part 1: Pathophysiology, symptoms, burden, diagnosis, and assessment D Weintraub, CL Comella, S Horn Am J Manag Care 14 (2 Suppl), S40-S48, 2008 | 341 | 2008 |
| Parkinson's disease: the quintessential neuropsychiatric disorder D Weintraub, DJ Burn Movement Disorders 26 (6), 1022-1031, 2011 | 323 | 2011 |
